FDA — authorised 25 July 1978
- Marketing authorisation holder: BRACCO
- Status: approved
FDA authorised Ametriodic Acid on 25 July 1978
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 25 July 1978.
BRACCO holds the US marketing authorisation.